Vitamin K2 Market By Type (MK-4, MK-7, Others), By Source (Animal-Based, Plant-Based, Synthetic), By Form (Powder, Liquid, Softgels & Tablets, Capsules), By Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Animal Feed, Cosmetics), By End-User (Infants, Children, Adults, Geriatrics), and By Distribution Channel (Online Sales, Offline Sales); Global Insights & Forecast (2024 – 2030)

Published: January, 2025  
|   Report ID: FB5056  
|   Food and Beverage

As per Intent Market Research, the Vitamin K2 Market was valued at USD 389.4 million in 2023 and will surpass USD 831.6 million by 2030; growing at a CAGR of 11.4% during 2024 - 2030.

The Vitamin K2 market is rapidly gaining traction, driven by its increasing importance in supporting bone and cardiovascular health. As an essential nutrient, Vitamin K2 plays a pivotal role in calcium regulation, ensuring that it is deposited in the bones and teeth rather than the arteries, which prevents arterial calcification. The growing awareness about the benefits of Vitamin K2 in supporting bone density, heart health, and overall wellness has resulted in an expanding market for supplements and fortified foods. As demand increases, innovations in production, along with a diverse range of product formats, are facilitating the accessibility and consumption of Vitamin K2, contributing to its market growth.

MK-7 Segment is Fastest Growing Owing to Higher Bioavailability

Among the different types of Vitamin K2, MK-7 (Menaquinone-7) is the fastest-growing subsegment, largely due to its superior bioavailability and longer half-life compared to other forms like MK-4. MK-7 is derived from natto, a traditional Japanese fermented food, and is widely used in dietary supplements due to its efficacy in maintaining bone health and preventing cardiovascular diseases. Studies have shown that MK-7 is more readily absorbed by the body, making it a preferred choice for both consumers and manufacturers in the health and wellness industry.

As a result, MK-7 has seen a surge in demand, particularly in the Western markets, where consumers are becoming more health-conscious and seeking products that can effectively support bone health, cardiovascular well-being, and overall vitality. The growing adoption of MK-7 supplements in mainstream health and wellness routines is expected to drive the expansion of this subsegment in the coming years.

Vitamin K2 Market Size 2030

Animal-Based Source is Largest Due to High Nutritional Value

The Animal-Based source segment remains the largest in the Vitamin K2 market, owing to the higher nutritional value and bioavailability of Vitamin K2 derived from animal-based products. These sources typically include egg yolks, dairy products, and certain meats, which naturally contain MK-4, a potent form of Vitamin K2. Since MK-4 is the most bioavailable form of Vitamin K2, it has long been the preferred choice for supplementation. Moreover, animal-based Vitamin K2 sources are often perceived as more effective by consumers seeking high-quality supplements that can yield noticeable health benefits.

This segment’s dominance is bolstered by the consistent demand for Vitamin K2 in the pharmaceutical industry and the growth of functional foods and beverages. Additionally, consumer preference for animal-based sources remains strong, especially in markets with a high consumption of dairy and animal products, such as Europe and North America.

Softgels & Tablets Form is Largest Due to Consumer Convenience

Among the various forms of Vitamin K2 supplements, Softgels & Tablets are the largest subsegment, primarily driven by their consumer convenience, precise dosage, and ease of consumption. Softgels and tablets offer a practical solution for those looking to integrate Vitamin K2 into their daily health regimen without any hassle. These forms are particularly popular among adults and geriatrics, who are the primary consumers of dietary supplements for bone health and cardiovascular support.

Additionally, softgels and tablets are highly preferred by manufacturers as they can effectively protect the integrity of the active ingredients, ensuring longer shelf life and consistent potency. The ongoing innovation in supplement formulations, which includes improved delivery systems for enhanced absorption, further fuels the popularity of this subsegment in the global market.

Dietary Supplements Application is Largest Due to High Demand for Bone Health

Dietary Supplements remain the largest application for Vitamin K2, driven by the growing consumer awareness surrounding bone health and the increasing prevalence of conditions such as osteoporosis and cardiovascular diseases. Vitamin K2 is widely recognized for its role in bone mineralization and its ability to regulate calcium in the body, preventing calcium buildup in the arteries. As the global population ages, there is a heightened demand for supplements that support bone density and overall skeletal health.

In addition to the rising geriatric population, dietary supplements are also gaining popularity among younger demographics, particularly in health-conscious markets. The growing awareness of Vitamin K2's health benefits is expected to continue propelling this segment, with new products entering the market targeting both preventive care and active health management.

Adults Segment is Largest Due to Preventive Health Focus

In the Adults end-user segment, Vitamin K2 is primarily consumed to prevent age-related bone loss and support cardiovascular health. The adult demographic, particularly those in their 30s to 50s, is increasingly focused on preventive health strategies, leading to a growing demand for supplements that can maintain bone density, prevent osteoporosis, and improve heart health. As adults are becoming more proactive in managing their long-term health, Vitamin K2 has gained significant traction due to its proven efficacy in promoting bone health and cardiovascular function.

The focus on adult consumers is evident in the rapid expansion of the dietary supplements market, with adult-targeted Vitamin K2 products being marketed for their preventive and therapeutic benefits. This demographic is expected to continue driving the growth of Vitamin K2 supplements as part of an overall trend toward healthier, more active lifestyles.

Online Sales Distribution Channel is Fastest Growing Due to E-Commerce Growth

The Online Sales distribution channel is experiencing the fastest growth in the Vitamin K2 market, primarily due to the expanding reach of e-commerce and online retail platforms. Consumers increasingly prefer the convenience of purchasing supplements from the comfort of their homes, especially with the added benefit of accessing a wide range of products and competitive prices. Online platforms also provide an easy way for consumers to compare different Vitamin K2 brands, read reviews, and choose products that best suit their needs.

This growth in online sales is also fueled by the increasing trust in online retailers, coupled with the rise of digital marketing and influencer-driven trends. The accessibility of Vitamin K2 supplements through online platforms, including major e-commerce websites like Amazon, has greatly contributed to the fast-paced expansion of this segment.

Asia-Pacific Region is Fastest Growing Due to Rising Health Awareness

The Asia-Pacific (APAC) region is the fastest-growing market for Vitamin K2, driven by an increase in health awareness, rising disposable incomes, and a growing aging population. Countries like Japan, China, and India are witnessing a surge in demand for Vitamin K2 supplements, particularly for bone health and cardiovascular support. Japan, in particular, has a long-standing tradition of consuming natto (fermented soybeans), which is a natural source of MK-7, contributing to a high level of awareness regarding the benefits of Vitamin K2.

As consumers in APAC continue to embrace Western health trends, including dietary supplements and functional foods, the region is expected to remain a key growth driver for the Vitamin K2 market. The increasing penetration of e-commerce in countries like China and India further supports the expansion of Vitamin K2 products across the region.

Vitamin K2 Market Share by region 2030

Leading Companies and Competitive Landscape

Key players in the global Vitamin K2 market include Kappa Bioscience, Nutraceutical Corporation, BASF SE, DSM Nutritional Products, and MenaQ7 (Novo Nordisk). These companies have been pivotal in driving innovation in Vitamin K2 production, particularly MK-7, and have strategically expanded their product portfolios to cater to the growing demand for both dietary supplements and functional foods. The competitive landscape is characterized by product diversification, with many companies focusing on improving bioavailability, sustainability, and sourcing from plant-based and synthetic alternatives.

The market is highly competitive, with both large multinational corporations and specialized players competing for market share. Companies are increasingly focusing on expanding distribution channels, particularly online sales, and forging partnerships with health and wellness brands to capture the growing consumer interest in preventive healthcare and natural supplements. As the market evolves, leading companies are expected to continue investing in research and development to enhance the efficacy and accessibility of Vitamin K2 products

List of Leading Companies:

  • Kappa Bioscience
  • Nutraceutical Corporation
  • DSM Nutritional Products
  • BASF SE
  • Chong Kun Dang Pharmaceutical Corp.
  • NattoPharma
  • Frutarom Health
  • MenaQ7 (Novo Nordisk)
  • Herbalife Nutrition
  • Amway
  • Bionova
  • Swisse Wellness
  • Tishcon Corporation
  • Jarrow Formulas
  • BioGenetics

Recent Developments:

  • Kappa Bioscience Launches MK-7 Product Line Kappa Bioscience expanded its MK-7 product line with the launch of a new, high-quality vitamin K2 supplement aimed at improving bone health.
  • BASF Partners with BioGenetics for Vitamin K2 Innovation BASF entered into a strategic partnership with BioGenetics to enhance its Vitamin K2 offerings, focusing on plant-based sources and sustainable production.
  • MenaQ7 (Novo Nordisk) Expands MK-7 Production MenaQ7 announced the expansion of its MK-7 production capabilities, ensuring a steady supply of Vitamin K2 for global dietary supplement markets.
  • Herbalife Nutrition Introduces New Vitamin K2 Supplement Herbalife Nutrition unveiled a new Vitamin K2 product designed to support joint and bone health, catering to the growing demand in the wellness sector.
  • Swisse Wellness Receives Regulatory Approval for Vitamin K2 Swisse Wellness received regulatory approval in Europe for its enhanced Vitamin K2 supplement, marking a significant milestone in their global expansion strategy

Report Scope:

Report Features

Description

Market Size (2023)

USD 389.4 Million

Forecasted Value (2030)

USD 831.6 Million

CAGR (2024 – 2030)

11.4%

Base Year for Estimation

2023

Historic Year

2022

Forecast Period

2024 – 2030

Report Coverage

Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments

Segments Covered

Vitamin K2 Market By Type (MK-4, MK-7, Others), By Source (Animal-Based, Plant-Based, Synthetic), By Form (Powder, Liquid, Softgels & Tablets, Capsules), By Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Animal Feed, Cosmetics), By End-User (Infants, Children, Adults, Geriatrics), and By Distribution Channel (Online Sales, Offline Sales)

Regional Analysis

North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa)

Major Companies

Kappa Bioscience, Nutraceutical Corporation, DSM Nutritional Products, BASF SE, Chong Kun Dang Pharmaceutical Corp., NattoPharma, Frutarom Health, MenaQ7 (Novo Nordisk), Herbalife Nutrition, Amway, Bionova, Swisse Wellness, Tishcon Corporation, Jarrow Formulas, BioGenetics

Customization Scope

Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements

1. Introduction

   1.1. Market Definition

   1.2. Scope of the Study

   1.3. Research Assumptions

   1.4. Study Limitations

2. Research Methodology

   2.1. Research Approach

      2.1.1. Top-Down Method

      2.1.2. Bottom-Up Method

      2.1.3. Factor Impact Analysis

  2.2. Insights & Data Collection Process

      2.2.1. Secondary Research

      2.2.2. Primary Research

   2.3. Data Mining Process

      2.3.1. Data Analysis

      2.3.2. Data Validation and Revalidation

      2.3.3. Data Triangulation

3. Executive Summary

   3.1. Major Markets & Segments

   3.2. Highest Growing Regions and Respective Countries

   3.3. Impact of Growth Drivers & Inhibitors

   3.4. Regulatory Overview by Country

4. Vitamin K2 Market, by Type (Market Size & Forecast: USD Million, 2022 – 2030)

   4.1. MK-4 (Menaquinone-4)

   4.2. MK-7 (Menaquinone-7)

   4.3. Others (MK-6, MK-8, MK-9)

5. Vitamin K2 Market, by Source (Market Size & Forecast: USD Million, 2022 – 2030)

   5.1. Animal-Based

   5.2. Plant-Based

   5.3. Synthetic

6. Vitamin K2 Market, by Form (Market Size & Forecast: USD Million, 2022 – 2030)

   6.1. Powder

   6.2. Liquid

   6.3. Softgels & Tablets

   6.4. Capsules

7. Vitamin K2 Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030)

   7.1. Dietary Supplements

   7.2. Functional Foods & Beverages

   7.3. Pharmaceuticals

   7.4. Animal Feed

   7.5. Cosmetics

8. Vitamin K2 Market, by End-User (Market Size & Forecast: USD Million, 2022 – 2030)

   8.1. Infants

   8.2. Children

   8.3. Adults

   8.4. Geriatrics

9. Vitamin K2 Market, by Distribution Channel (Market Size & Forecast: USD Million, 2022 – 2030)

   9.1. Online Sales

   9.2. Offline Sales (Pharmacies, Supermarkets, Health Stores)

10. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030)

   10.1. Regional Overview

   10.2. North America

      10.2.1. Regional Trends & Growth Drivers

      10.2.2. Barriers & Challenges

      10.2.3. Opportunities

      10.2.4. Factor Impact Analysis

      10.2.5. Technology Trends

      10.2.6. North America Vitamin K2 Market, by Type

      10.2.7. North America Vitamin K2 Market, by Source

      10.2.8. North America Vitamin K2 Market, by Form

      10.2.9. North America Vitamin K2 Market, by Application

      10.2.10. North America Vitamin K2 Market, by

      10.2.11. North America Vitamin K2 Market, by Distribution Channel

      10.2.12. By Country

         10.2.12.1. US

               10.2.12.1.1. US Vitamin K2 Market, by Type

               10.2.12.1.2. US Vitamin K2 Market, by Source

               10.2.12.1.3. US Vitamin K2 Market, by Form

               10.2.12.1.4. US Vitamin K2 Market, by Application

               10.2.12.1.5. US Vitamin K2 Market, by

               10.2.12.1.6. US Vitamin K2 Market, by Distribution Channel

         10.2.12.2. Canada

         10.2.12.3. Mexico

    *Similar segmentation will be provided for each region and country

   10.3. Europe

   10.4. Asia-Pacific

   10.5. Latin America

   10.6. Middle East & Africa

11. Competitive Landscape

   11.1. Overview of the Key Players

   11.2. Competitive Ecosystem

      11.2.1. Level of Fragmentation

      11.2.2. Market Consolidation

      11.2.3. Product Innovation

   11.3. Company Share Analysis

   11.4. Company Benchmarking Matrix

      11.4.1. Strategic Overview

      11.4.2. Product Innovations

   11.5. Start-up Ecosystem

   11.6. Strategic Competitive Insights/ Customer Imperatives

   11.7. ESG Matrix/ Sustainability Matrix

   11.8. Manufacturing Network

      11.8.1. Locations

      11.8.2. Supply Chain and Logistics

      11.8.3. Product Flexibility/Customization

      11.8.4. Digital Transformation and Connectivity

      11.8.5. Environmental and Regulatory Compliance

   11.9. Technology Readiness Level Matrix

   11.10. Technology Maturity Curve

   11.11. Buying Criteria

12. Company Profiles

   12.1. Kappa Bioscience

      12.1.1. Company Overview

      12.1.2. Company Financials

      12.1.3. Product/Service Portfolio

      12.1.4. Recent Developments

      12.1.5. IMR Analysis

    *Similar information will be provided for other companies 

   12.2. Nutraceutical Corporation

   12.3. DSM Nutritional Products

   12.4. BASF SE

   12.5. Chong Kun Dang Pharmaceutical Corp.

   12.6. NattoPharma

   12.7. Frutarom Health

   12.8. MenaQ7 (Novo Nordisk)

   12.9. Herbalife Nutrition

   12.10. Amway

   12.11. Bionova

   12.12. Swisse Wellness

   12.13. Tishcon Corporation

   12.14. Jarrow Formulas

   12.15. BioGenetics

13. Appendix

Let us connect with you TOC

I have read the Terms & Conditions and Privacy Policy I agree to its terms

A comprehensive market research approach was employed to gather and analyze data on the Vitamin K2 Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Vitamin K2 Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.

Research Approach - Vitamin K2 Market

Secondary Research

Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.

Primary Research

Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:

  • Validating findings and assumptions derived from secondary research
  • Gathering qualitative and quantitative data on market trends, drivers, and challenges
  • Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
  • Assessing the supply-side landscape, including technological advancements and recent developments

Market Size Assessment

A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Vitamin K2 Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:

  1. Identification of key industry players and relevant revenues through extensive secondary research
  2. Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
  3. Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources

Bottom Up and Top Down - Vitamin K2 Market

Data Triangulation

To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.

NA

Let us connect with you


I have read the Terms & Conditions and Privacy Policy I agree to its terms
Available Formats
REPORT BUYING OPTIONS


Buy Now